A new device can detect severe heart attacks in more patients, leading to better diagnoses and faster treatment, according to new research. The new 80-lead electrocardiogram (ECG/EKG), PRIME ECG, can give physicians a broader reading of the heart muscle than the traditional 12-lead ECG. The increased number of the leads means some can be applied to the patient’s front and back across the patient’s chest to give a clear picture of the entire heart. The University of Cincinnati’s emergency medicine associate professor Gregory Fermann has studied the device for the past two years. From the trials conducted on 1,830 patients from 11 medical centres across the country, the PRIME ECG in an emergency department setting provided a 27.5% increase in the detection of ST-elevation myocardial infarction, the study said. Be a part of Elets Collaborative Initiatives. Join Us for
Upcoming Events and explore business opportunities. Like us on
Facebook , connect with us on
LinkedIn and follow us on
Twitter ,
Instagram. "Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
Related Research
NFHS-6 Reveals India’s Mixed Health Transition: Child Malnutrition Falls, Healthcare Access Improves, But Obesity & Lifestyle Diseases Surge
India’s latest National Family Health Survey (NFHS-6) paints a complex portrait of the country’s public health journ...
P&G Health and IMA Unveil India’s First Evidence-Based Patient Recovery Guidelines Focused on Micronutrients
Strengthening post-illness care in India, Procter & Gamble Health Limited has partnered with the Indian Medical Asso...
30 Years of Scientific Rigour: DiagnoSearch Reinforces Its Role in Accelerating Pharma Pipelines
DiagnoSearch Life Sciences, one of India’s longest-standing and most trusted Clinical Research Organisations (CROs), h...
Servier India Partners with MedGenome & Strand Life Sciences, Expanding AML & CCA Testing
To advance India's precision oncology and equitable access to molecular diagnostics, Servier India, a subsidiary of the ...
One in Four Indians at Risk of Heart Disease as Lipid Imbalances Rise Across Age Groups: Metropolis Study | World Heart Day Special
Metropolis Healthcare Limited, one of India’s largest and most respected pathology networks, has released a nationwide...
IIT Roorkee Scientists Unveil Novel Drug Candidate to Tackle Antibiotic Resistance Crisis
Scientists at the Indian Institute of Technology (IIT) Roorkee have identified a potential drug candidate capable of res...
82% Prefer Diagnostic Centres Over Hospitals in India: ekincare Report
A new data-backed report by ekincare uncovers a decisive change in India’s preventive healthcare landscape, placing di...
Axiom-4 to Test First FDA-Approved Cancer Drug in Space, Pioneering Microgravity-Driven Oncology Research
In a landmark development for pharmaceutical research, the upcoming Axiom-4 (Ax-4) mission is set to test Rebecsinib, th...
Indian Life Sciences Sector Pioneers Future-Ready Lab Design, Setting Global Benchmark: Unispace Survey
A new global survey by Unispace, a leader in workplace strategy, design, and construction, reveals that India's life sci...
Govt Funds ₹330 Cr AI-Healthcare CoE by IIT Delhi & AIIMS Under ‘Make AI Work for India’ Initiative
The Indian Institute of Technology (IIT) Delhi and the All India Institute of Medical Sciences (AIIMS) Delhi have signed...
